Your browser doesn't support javascript.
loading
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1.
Heibl, Sonja; Buxhofer-Ausch, Veronika; Schmidt, Stefan; Webersinke, Gerald; Lion, Thomas; Piringer, Gudrun; Kuehr, Thomas; Wolf, Dominik; Melchardt, Thomas; Greil, Richard; Thaler, Josef.
Affiliation
  • Heibl S; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Buxhofer-Ausch V; Department of Internal Medicine I with Hematology, Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria.
  • Schmidt S; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Webersinke G; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
  • Lion T; Labor für Molekulargenetische Diagnostik, Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Austria.
  • Piringer G; Labdia Labordiagnostik GmbH, Children's Cancer Research Institute, Vienna, Austria.
  • Kuehr T; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Wolf D; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Melchardt T; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
  • Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
  • Thaler J; Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Cancer Cluster Salzburg, Salzburg, Austria.
Hematol Oncol ; 38(5): 792-798, 2020 Dec.
Article in En | MEDLINE | ID: mdl-32757230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United kingdom